Rchr
J-GLOBAL ID：201001066072173180   Update date: Apr. 15, 2024

Takahashi Chiaki

タカハシ チアキ | Takahashi Chiaki
Affiliation and department：
Kanazawa University Cancer Research Institute

About Kanazawa University Cancer Research Institute


Homepage URL  (2)： http://omb.w3.kanazawa-u.ac.jp/index.html ,  http://www.kanazawa-u.ac.jp/~ganken/index.html
Research field  (2)： Tumor biology ,  Pathobiochemistry
Research keywords  (6)： 腫瘍遺伝学 ,  分子生物学 ,  分子腫瘍学 ,  Cancer Genetics ,  Molecular Biology ,  Molecular Oncology
Research theme for competitive and other funds  (21)：
  • 2020 - 2024 RB1 tumor suppressor functions in metabolism
  • 2019 - 2022 Analysis of DIP2C as a novel regulator for epithelial-mesenchymal transition of rheumatoid arthritis synovium and a potential therapeutic target
  • 2019 - 2021 Drug development targeting metabolic vulnerability associated with SUCLA2 loss
  • 2017 - 2020 Metabolic regulation by RB tumor suppressor gene
  • 2017 - 2019 Drug discovery based on collateral lethality
Show all
Papers (88)：
  • Nobuhiro Okada, Chihiro Ueki, Masahiro Shimazaki, Goki Tsujimoto, Susumu Kohno, Hayato Muranaka, Kiyotsugu Yoshikawa, Chiaki Takahashi. NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism. Communications biology. 2023. 6. 1. 596-596
  • Masafumi Noguchi, Susumu Kohno, Anna Pellattiero, Yukino Machida, Keitaro Shibata, Norihito Shintani, Takashi Kohno, Noriko Gotoh, Chiaki Takahashi, Atsushi Hirao, et al. Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line. Cell death & disease. 2023. 14. 4. 241-241
  • Christopher Noyes, Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala, Shakson Isaac, Nagib Ahsan, Erik Knelson, Amir Vajdi, Tetsuo Tani, et al. The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells. Communications Biology. 2023. 6. 1
  • Loc Thi Pham, Hui Peng, Masaya Ueno, Susumu Kohno, Atuso Kasada, Kazuyoshi Hosomichi, Takehiro Sato, Kenta Kurayoshi, Masahiko Kobayashi, Yuko Tadokoro, et al. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia. Biochemical and Biophysical Research Communications. 2022. 621. 74-79
  • Sheng J, Kohno S, Okada N, Okahashi N, Teranishi K, Matsuda F, Shimizu S, Linn P, Nagatani N, Yamamura M, et al. Treatment of retinoblastoma 1-intact hepatocellular carcinoma with cyclin-dependent kinase 4/6 inhibitor combination therapy. 2021
ｍore...
MISC (40)：
ｍore...
Education (2)：
  • 1992 - 1996 Kyoto University
  • 1984 - 1990 Kyoto University Faculty of Medicine
Professional career (1)：
  • MD., Ph. D., (Kyoto University)
Work history (9)：
  • 2011/04 - 現在 Kanazawa University Cancer Research Institute
  • 2009/12 - 2011/03 金沢大学がん研究所教授
  • 2008/04 - 2009/11 京都大学医学研究科研究員
  • 2004/01 - 2008/03 Kyoto University Graduate School of Medicine
  • 1996/06 - 2003/12 Kyoto University Graduate School of Medicine
Show all
Committee career (3)：
  • - 現在 日本癌学会 評議員
  • 2015 - 2016 AMED プログラムオフィサー
  • 2007 - 2011 日本病態プロテアーゼ学会 評議員
Awards (1)：
  • 2004 - 日本癌学会奨励賞
Association Membership(s) (8)：
AACR ,  日本癌治療学会 ,  ASBMB ,  JAPAN SOCIETY FOR CELL BIOLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPANESE BIOCHEMICAL SOCIETY ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM